全球远端患者监护(RPM) 产业透过策略合作伙伴关係推动变革性成长：预测，2024-2028 年

Remote Patient Monitoring Sector Driving Transformational Growth through Strategic Partnerships: Forecast-Global, 2024-2028

出版日期: 2024年06月28日 | 出版商:

Frost & Sullivan | 英文 62 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录

产业融合数位化加剧竞争环境

远端患者监护(RPM) 包括旨在允许临床医生远端收集和监测患者生物识别资料和行为的设备和IT基础设施。该基础设施包括软体、网关、平台、资料传输和管理系统、网路等。虽然智慧型手机、智慧型手錶和健身追踪器等消费者穿戴式装置可以提供类似的资料（例如心率、睡眠品质、行动性），但本研究仅关注 RPM 技术

这项全球分析概述了主要市场，重点关注美国，该地区的高资料可用性正在推动该地区Start-Ups的显着成长和创新。 RPM 产业根据持续关注以及产品和服务提供范围进行细分。公司可能会为特定护理点提供一系列产品，也可能专门为更广泛的用途提供产品和服务。儘管这些产品之间存在差异，但 Frost & Sullivan 并未提供任何有关产品细分的预测，因为该行业主要将这些产品和服务作为捆绑解决方案进行销售。

这种全面的分析为医疗保健相关人员提供了重要的见解，以应对不断变化的 RPM 格局，揭示对策略决策至关重要的成长机会、区域趋势和经营模式分析。

分析范围
行业细分
行业区隔：连续护理
行业细分：产品和服务
主要竞争对手
远端患者监护的结构
远端患者监护Start-Ups：投资前景
远端患者监护：付款人的角色
远端患者监护：付款人合作伙伴
FDA 的居家医疗计划
成长指标
生长促进因子
成长抑制因素
预测假设
收益预测
按 Continuum of Care 分類的收益预测
按地区分類的收益预测
收益预测分析
价格趋势和预测分析
竞争环境
收益占有率
收益占有率分析
竞争环境 -案例研究

成长机会分析：慢性病护理

成长指标
收益预测
预测分析

成长机会分析：过渡性护理

成长指标
收益预测
预测分析

成长机会分析：重症加护

成长指标
收益预测
预测分析

成长机会宇宙

成长机会1：心理健康/行为健康
成长机会2：免疫疾病
成长机会 3：女性健康中的疼痛管理

下一步

简介目录

Product Code: KA37-48

Industry Convergence and Digitalization Intensify the Competitive Environment

Remote patient monitoring (RPM) encompasses devices and IT infrastructure designed to enable clinicians to collect and monitor patients' biometric data and behaviors remotely. This infrastructure includes software, gateways, platforms, data transmission and management systems, and networks. While consumer-grade wearables, including smartphones, smartwatches, and fitness trackers, can provide similar data (e.g., heart rate, sleep quality, mobility), this study focuses exclusively on clinician-intended RPM technologies due to their higher consistency and accuracy.

RPM differs from telehealth, which primarily involves communication via video or audio between patients and clinicians. Instead, RPM focuses on the remote collection of vital statistics, biochemistry, and cardiac rhythms, along with related products and services that transmit and provide clinical insights into the collected data. Despite the integral role of EMR/EHR technology in RPM workflows, this study excludes these technologies from market calculations, treating them as separate entities.

Many consumer-grade wearables (e.g., smartphones, smartwatches, and fitness trackers) provide data similar to devices that are part of the RPM industry (e.g., heart rate and rhythm, sleep length and quality, and mobility). However, for this analysis, we limit the definition of RPM to technologies specifically intended for use by clinicians to monitor patients. While it is possible to use consumer-grade devices in medical RPM in the future, there is a wider variance in their consistency and accuracy, so clinicians do not currently widely accept them.

This global analysis provides an overview of major markets, primarily the United States due to the greater availability of data and significant growth and innovation driven by start-ups in the region. The RPM industry is segmented by care continuum and the range of products and services offered. Companies may offer a suite of products for specific points of care or specialize in products or services with broader applications. While the differentiation among these offerings is noted, Frost & Sullivan does not provide forecasts on product segmentation, as the industry predominantly sells these products and services as bundled solutions.

The comprehensive analysis equips healthcare stakeholders with critical insights to navigate the evolving RPM landscape, highlighting growth opportunities, regional trends, and business model analyses essential for strategic decision-making.

Strategic Imperatives

Why is it Increasingly Difficult to Grow?
The Strategic Imperative 8™
The Impact of the Top 3 Strategic Imperatives on the Remote Patient Monitoring Industry
Growth Opportunities Fuel the Growth Pipeline Engine™